Skip to main content
OpenTrials
Completed

NCT Number: NCT02309398

CCC Project - Atrial Fibrillation

The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing An Zhen Hospital

Beijing, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospitalized patients with discharge diagnosis as atrial fibrillation in 150 tertiary and 100 secondary hospitals.

Exclusion criteria

None

Treatment and study plan

Primary outcomes

  1. The overall composite of six performance measures for AF care

    Time frame: Duration of hospital stay, an expected average of 1 week

    Performance measures for AF care including:

    • Proportion of patients received assessment of thromboembolic risk factors
    • Proportion of patients discharged on warfarin or other anticoagulant drug
    • Proportion of patients discharged on warfarin who have PT/INR follow-up planned prior to hospital discharge
    • Proportion of patients with left ventricular systolic dysfunction prescribed an ACEI or ARB at hospital discharge
    • Proportion of patients with left ventricular systolic dysfunction prescribed a beta blocker at hospital discharge
    • Proportion of patients with either coronary artery disease, cerebrovascular accident/transient ischemic attack, peripheral vascular disease or diabetes who were prescribed a statin at hospital discharge

Sponsors and collaborators

Lead sponsor

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Other

Collaborators

  • American Heart Association
  • Chinese Society of Cardiology

Registry information

Official study title

Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Atrial Fibrillation

Important dates

Study start
2015
Primary completion
2020
Study completion
2020
First posted
Dec 5, 2014
Registry last updated
Jan 27, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.